Biovest Expanding in Coon Rapids, Minnesota, to Develop Cancer Vaccine
The Coon Rapids Housing and Redevelopment Authority will contribute an additional $100,000 and facility owner JMS Holdings will invest $1.15 million in facility improvements.
"The Minneapolis area is rich with resources vital to a biotechnology company's growth needs, and it is with great appreciation that we thank the state of Minnesota, the city of Coon Rapids, and JMS Holdings for investing in our future," said Biovest President Samuel Duffey.
Biovest will add 14 jobs to its existing work force of 24 employees. It is planning to produce the first cancer vaccine to treat non-Hodgkin's lymphoma. The company has been located in Coon Rapids for nearly 30 years.
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
A Changing Food Manufacturing Industry
2017 Food Processing
Front Line: Manufacturers Look to Nontraditional Locations
The 3 Cs of Successful Site Selection: Company, Culture, and Community
2019 Gold & Silver Shovel Awards: Recipients Garnered Large Job-Creating and Investment Projects in Diverse Industries